4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001415889-24-006766
Director sold 46,534 shares at $30.05 ($1,398,347)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rhodes Jason P Director | 2024-03-01 | Sale 10b5-1 | −29,435 | $30.05 | $884,522 | 1,458,691 | I |
| Rhodes Jason P Director | 2024-03-01 | Sale 10b5-1 | −17,099 | $30.05 | $513,825 | 847,388 | I |
| Open-market sales · 46,534 sh · avg $30.05 · $1,398,347 | |||||||
Loading xslF345X05/form4-03052024_100311.xml…